NDC 0300-3612-24 - Lupron
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0300-3612
- Requested NDC
- 0300-3612-24
- Package NDCs from labels
- 0300-3612-28, 0300-3612-24
- Manufacturer
- TAP Pharmaceutical Products Inc.
- Effective date
- 2008-02-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LUPRON ® INJECTION (leuprolide acetate) | TAP Pharmaceutical Products Inc. | 2008-02-29 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0300-3612-24 | Lupron | 6 in 1 CARTON | INJECTION, SOLUTION | 6 | 1 | |
| 0300-3612-24 | Lupron | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 0300-3612-28 | Lupron | 2.8 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 2.8 mL | 5 mg in 1mL | 1 |
| 0300-3612-28 | Lupron | 1 in 1 CARTON | INJECTION, SOLUTION | 5 mg in 1mL | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| leuprolide acetate | LEUPROLIDE ACETATE | Amneal Pharmaceuticals LLC | 4838c674-044e-46b2-81e7-c691b99d8fa5 | 2026-05-28 | Warnings, Adverse reactions | 545835 |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Zydus Pharmaceuticals USA Inc. | 35634415-000f-47db-9bd7-9e16eef3f02e | 2026-05-25 | Warnings, Adverse reactions | 545835 |
| Leuprolide Acetate | LEUPROLIDE ACETATE | Sandoz Inc | 8bd72c1e-2751-4498-a346-bc5e3acbba0b | 2026-05-19 | Warnings, Adverse reactions | 545835 |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Eugia US LLC | 49a1d0c1-304c-46f2-a780-bd940ae1ced0 | 2026-05-08 | Warnings, Adverse reactions | 545835 |
| leuprolide acetate | LEUPROLIDE ACETATE | Sun Pharmaceutical Industries, Inc. | a3b01473-30c7-4945-bd60-2484221aaaad | 2026-04-24 | Warnings, Adverse reactions | 545835 |
| Leuprolide Acetate | LEUPROLIDE ACETATE | Meitheal Pharmaceuticals Inc | d6bd26bd-b8d8-4c5a-bc5c-7b8a1efaa584 | 2026-04-23 | Warnings, Adverse reactions | 545835 |
| leuprolide acetate | LEUPROLIDE ACETATE | UBI Pharma Inc. | cd46628f-055f-4da9-8c38-fa69af34eb4d | 2026-03-29 | Warnings, Adverse reactions | 545835 |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Zydus Lifesciences Limited | 4bae0e2a-dd36-4987-85ee-36a52e642ec7 | 2026-02-09 | Warnings, Adverse reactions | 545835 |
| leuprolide acetate | LEUPROLIDE ACETATE | PAI Holdings, LLC dba PAI Pharma | 19be0b7f-e68a-4547-9e49-b51b12821907 | 2026-01-16 | Warnings, Adverse reactions | 545835 |
| Leuprolide Acetate | LEUPROLIDE ACETATE | VGYAAN Pharmaceuticals LLC | bec9077a-3f04-4887-856d-dde2de24584d | 2025-11-21 | Warnings, Adverse reactions | 545835 |
| Leuprolide Acetate | LEUPROLIDE ACETATE | NorthStar RxLLC | 0cf31b40-816b-d055-e063-6294a90af5d0 | 2025-06-24 | Warnings, Adverse reactions | 545835 |
| LEUPROLIDE ACETATE | LEUPROLIDE ACETATE | Endo USA, Inc. | 290b0716-2fd5-43a1-8d3c-4857c1b2eefa | 2024-06-10 | Warnings, Adverse reactions | 545835 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.